Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:35 PM
Ignite Modification Date:
2025-12-24 @ 5:35 PM
NCT ID:
NCT06418568
Eligibility Criteria:
Inclusion Criteria:
1. Age ≥ 18 years, any gender;
2. Diagnosis of melasma;
3. Able to comprehend and voluntarily sign a written informed consent form, and able to complete the treatment and follow-up as required.
Exclusion Criteria:
1. History of other pigmentary disorders such as lentigines, Ota nevus, freckles, etc.;
2. History of oral retinoid or tetracycline-class photosensitizing drugs within the past 6 months prior to treatment;
3. History of facial injections, fillers, chemical peels, laser or radiofrequency treatments, or other treatments targeting pigmentation within the past 6 months prior to treatment;
4. Abnormal coagulation function;
5. History of oral glucocorticoids or immunosuppressive agents within the past 3 months prior to treatment;
6. Patients with malignant tumors;
7. Pregnant or lactating women;
8. Patients with active herpes simplex or herpes zoster on the face.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06418568
Study Brief:
Protocol Section:
NCT06418568